Newsfile Corp
15 Jun 2026, 12:35 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
NeOnc Technologies is approaching anticipated Phase 2 clinical updates for its lead programs NEO100 and NEO212. — Phase 2 data are critical value-inflection events in biotech that can lead to massive price swings based on efficacy and safety results.
+0.80CEO Amir Heshmatpour has purchased over $500,000 of company stock recently, with cumulative insider buys near $1 million over the past year. — Significant insider buying is generally viewed as a strong signal of management's confidence in upcoming clinical catalysts.
+0.50NeOnc entered a Securities Purchase Agreement to raise up to $5 million via Series A Convertible Preferred Stock. — Secures necessary runway for clinical development, though the impact is tempered by the potential for future dilution.
+0.40Continue reading
6 related stories
Top 2 movers · tap to explore
The new financing structure includes a $1.00 conversion floor and provisions allowing the company to redeem securities before conversion. — These terms reduce the immediate risk of death-spiral dilution compared to traditional floating-rate convertible notes.
+0.30Major financial institutions, including Bank of America, State Street, and Barclays, have expanded their institutional ownership in the company. — Increased institutional backing suggests improved professional validation and provides a more stable shareholder base.
+0.30Which stocks this story touches
The company secured $5 million in financing, saw record trading volume, and has significant insider buying from the CEO.
Mentioned as an institutional owner of NeOnc, implying a positive investment position.
Mentioned as an institutional owner of NeOnc, implying a positive investment position.
Mentioned as an institutional owner of NeOnc, implying a positive investment position.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
PRNewsWire
3h ago
